Mental Health Treatment Utilization Among Patients Receiving Collaborative Care for Co-occurring Disorders.
Psychiatr ServAug 6, 2026 (epub)
Clinical ResearchPsychiatry
Alexandra Bilder, Lauren Kelly, Rebecca Weir et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial analyzed 400 patients receiving collaborative care for opioid use disorder with co-occurring depression or PTSD. Results indicated that 51% received psychiatric medication and 44% received counseling. Co-use of stimulants and lower education were linked to reduced likelihood of treatment receipt.
Key findings
- 51% of participants received psychiatric medication during the 6-month intervention.
- 44% of participants received counseling during the same period.
- Co-use of stimulants was associated with lower likelihood of receiving psychiatric medication (AOR=0.95).
- Lower education levels correlated with reduced likelihood of receiving counseling (AOR=0.92).
Why it matters
Understanding treatment utilization in patients with co-occurring disorders is crucial for addressing mental health needs. The findings highlight significant gaps in treatment access, which can inform future interventions and policy decisions.